Physician

Travis Sifers, M.D.

According to 2025 Medicare claims, Travis Sifers, M.D. (NPI: 1922368539) practices allergy/immunology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is KANSAS CITY PHYSICIAN PARTNERS INC (NPI: 1831531466; TIN: 463233706) and primary practice location at 64086-5799. Sifers is affiliated with the Centrus Health of Kansas LLC (ACO ID: A5305), participating under the MSSP model.

Sifers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 255 traditional Medicare patients, billed 42,643 HCPCS/CPT codes, and received $2,548,665 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 713 prescription claims across 173 beneficiaries totaling $255,434 in drug costs, led by Xolair (Omalizumab). DME data shows 65 claims. Open Payments data shows 4 records totaling $3,239. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,899 to $2,548,665. Similarly, Part D prescription costs have risen steadily, from $11,660 to $255,434. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	49	67	$3,899
2017	63	93	$4,538
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	101	14,159	$384,153
2021	181	26,145	$745,156
2022	221	39,074	$1,000,763
2023	240	36,527	$1,886,463
2024	255	42,643	$2,548,665

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	111	$11,660
2016	33	172	$15,225
2017	40	196	$11,146
2018	55	174	$67,472
2019	59	171	$67,760
2020	31	86	$24,303
2021	61	249	$63,208
2022	91	389	$164,927
2023	159	585	$226,878
2024	173	713	$255,434

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	142	142	$79,193
2019	420	472	$243,216
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	13	$33,949
2024	N/R	65	$119,769

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	63	86	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	93	114	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	87	113	$12
36415	Insertion of needle into vein for collection of blood sample	82	105	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	58	71	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	20	560	$80,571
Dupixent Pen	Dupilumab	13	364	$46,273
Dupixent Syringe	Dupilumab	12	336	$43,919
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	50	1,500	$31,116
Breo Ellipta	Fluticasone/Vilanterol	32	1,440	$18,449

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	13	$79,898
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$34,512
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	13	$4,285
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	13	$940
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	13	$134

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$3,239	ADMA BioManufacturing LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Travis Sifers, M.D.?

Tedicare shows public-source Medicare data for Travis Sifers, M.D. (NPI 1922368539), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Travis Sifers, M.D. have ACO affiliation data?

Travis Sifers, M.D. is shown with ACO affiliation data for Centrus Health of Kansas LLC (MSSP, ACO ID A5305).

What billing organization is linked to Travis Sifers, M.D.?

Travis Sifers, M.D. is linked to KANSAS CITY PHYSICIAN PARTNERS INC (billing NPI 1831531466) in the available physician profile data.

Does Travis Sifers, M.D. have Open Payments data?

Travis Sifers, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.